Delivery Order 36F79723D010E-36C26023F0120
Award Date
12/21/22
Potential Completion Date
12/21/23
Potential Value
$11K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Amylyx Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Amylyx Pharmaceuticals Inc., doing business as Amylyx, a self-certified small disadvantaged business. The contract, valued at $355,678.72, is for the provision of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS), to the Puget Sound VA Medical Center. The contract has an ultimate completion date of March 31, 2023. Amylyx holds several significant Indefinite Delivery...
This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Amylyx Pharmaceuticals Inc., a self-certified small disadvantaged business. The contract is for the provision of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS), to the VA's Veterans Integrated Service Network (VISN) 21. The contract has a ceiling value of $74,879.68 and a period of performance through July 11, 2023. Amylyx Pharmaceuticals holds several significant...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Amylyx Pharmaceuticals Inc. (Amylyx), a small disadvantaged business. The $250,414.72 firm fixed price contract is for the delivery of RELYVRIO, Amylyx's pharmaceutical product containing sodium phenylbutyrate and taurursodiol, which is indicated for the treatment of amyotrophic lateral sclerosis (ALS). This delivery order was placed against larger...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Amylyx Pharmaceuticals Inc. for the provision of the drug RELYVRIO, which contains the active ingredients sodium phenylbutyrate and taurursodiol. The contract has a potential value of $93,599.60 and a completion date of April 20, 2024. Amylyx, a self-certified small disadvantaged business, has provided RELYVRIO to the VA through multiple federal contracts,...
Amylyx Pharmaceuticals Inc. was awarded a $56,159.76 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to provide its amyotrophic lateral sclerosis drug RELYVRIO. The delivery order, which does not have a set-aside designation, has a completion date of May 28, 2024 and was awarded on February 27, 2024. Amylyx has previously received multiple prime contract awards totaling over $3 million from August 2023...
Amylyx Pharmaceuticals Inc. was awarded a firm fixed price delivery order for $204,836.65 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The delivery order is for the provision of RELYVRIO, Amylyx's pharmaceutical treatment for amyotrophic lateral sclerosis, to the place of performance in Cambridge, Massachusetts. The period of performance is from April 1, 2024 through June 30, 2024. Amylyx holds additional vehicles with the VA...
Amylyx Pharmaceuticals Inc. was awarded a $46,799.80 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to provide its amyotrophic lateral sclerosis drug RELYVRIO. The order, issued without a set-aside designation, has a period of performance through May 1, 2024 for delivery to a location in Cambridge, Massachusetts. Amylyx holds several federal vehicles that facilitate provision of its pharmaceutical...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $93,599.60 firm fixed price delivery order contract to Amylyx Pharmaceuticals Inc., doing business as Amylyx, of Cambridge, Massachusetts. The contract is for the delivery of RELYVRIO SODIUM PHENYLBUTYRATE to support VHA programs. Amylyx will provide the pharmaceutical product to multiple VA medical centers in the region from November 2023 through January 2024. No subcontractors...
Amylyx Pharmaceuticals Inc., doing business as Amylyx, has been awarded a $74,879.68 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA VHA VISN 21) to provide RELYVIO. The contract has a period of performance from July 13, 2023 through September 13, 2023 and will be performed in Cambridge, Massachusetts. VHA VISN 21 oversees healthcare services for veterans in northern New England. This delivery order...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $74,879.68 firm fixed price delivery order contract to Amylyx Pharmaceuticals Inc., doing business as Amylyx, of Cambridge, Massachusetts. The contract calls for Amylyx to provide sodium phenylbutyrate and taurursodiol powder packets for oral administration to support VHA programs. The place of performance is Amylyx's headquarters in Cambridge. The period of performance is from...